About this document
TGF-β2 as Biomarker in Osteogenic Assays by brnjgp is a document available to read on EtoBox.
This study investigates the osteogenic potency of human multipotent stromal cells (hMSC) using a modified assay that incorporates TGF-β2 as a key biomarker. The research highlights the importance of specific gene expression levels in differentiating between donor-specific hMSC populations and emphasizes the need for standardized potency assays in regenerative medicine. The findings suggest that TGF-β2, along with other extracellular matrix proteins, could enhance the reliability of potency assays for clinic
- Author
- brnjgp
- Language
- EN